Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | b-NGF | 69.0 | 53 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | b-NGF | 93.0 | 41 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | b-NGF | 79.0 | 47 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | b-NGF | 71.5 | 56 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | b-NGF | 96.0 | 42 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | b-NGF | 48.0 | 69 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 54.0 | 53 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 40.0 | 57 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 45.0 | 82 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 61.5 | 62 | |
RA2159 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 48.0 | 53 | |
N2586 | IL-17A | 100 | ng/mL | 1 | b-NGF | 112.0 | 42 | ||||
N2586 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 112.0 | 41 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 101.0 | 31 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 74.5 | 40 | |
N2586 | Tofacitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 84.0 | 40 | |
N2586 | IKK16 | 2.0 | uM | IL-17A | 100 | ng/mL | 1 | b-NGF | 65.0 | 50 | |
RA2159 | 1 | b-NGF | 51.0 | 36 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | b-NGF | 49.5 | 60 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | b-NGF | 33.5 | 68 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 1 | b-NGF | 43.0 | 87 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 1 | b-NGF | 40.0 | 79 | ||||
RA2159 | IKK16 | 2.0 | uM | 1 | b-NGF | 38.0 | 63 | ||||
RA2159 | JNK-IN-8 | 3.0 | uM | 1 | b-NGF | 34.5 | 48 | ||||
N2586 | 1 | b-NGF | 81.5 | 44 |